A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol

por Curtis, Jeffrey R., Churchill, Melvin, Kivitz, Alan, Samad, Ahmed, Gauer, Laura, Gervitz, Leon, Koetse, Willem, Melin, Jeffrey, Yazici, Yusuf
Publicado 2015

Efficacy of Epratuzumab, an Anti‐CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials...

por Gottenberg, Jacques‐Eric, Dörner, Thomas, Bootsma, Hendrika, Devauchelle‐Pensec, Valérie, Bowman, Simon J., Mariette, Xavier, Bartz, Holger, Oortgiesen, Marga, Shock, Anthony, Koetse, Willem, Galateanu, Catrinel, Bongardt, Sabine, Wegener, William A., Goldenberg, David M., Meno‐Tetang, Guy, Kosutic, Gordana, Gordon, Caroline
Publicado 2018

Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis

por Kang, Young Mo, Park, Young-Eun, Park, Won, Choe, Jung-Yoon, Cho, Chul-Soo, Shim, Seung-Cheol, Bae, Sang Cheol, Suh, Chang-Hee, Cha, Hoon-Suk, Koh, Eun Mi, Song, Yeong-Wook, Yoo, Bin, Lee, Shin-Seok, Park, Min-Chan, Lee, Sang-Heon, Arendt, Catherine, Koetse, Willem, Lee, Soo-Kon
Publicado 2018